1. Home
  2. CASI vs OMH Comparison

CASI vs OMH Comparison

Compare CASI & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • OMH
  • Stock Information
  • Founded
  • CASI 1991
  • OMH 2015
  • Country
  • CASI China
  • OMH Singapore
  • Employees
  • CASI N/A
  • OMH N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • CASI Health Care
  • OMH Finance
  • Exchange
  • CASI Nasdaq
  • OMH Nasdaq
  • Market Cap
  • CASI 35.8M
  • OMH 35.8M
  • IPO Year
  • CASI 1996
  • OMH 2023
  • Fundamental
  • Price
  • CASI $2.01
  • OMH $1.36
  • Analyst Decision
  • CASI Strong Buy
  • OMH Hold
  • Analyst Count
  • CASI 1
  • OMH 1
  • Target Price
  • CASI $4.00
  • OMH N/A
  • AVG Volume (30 Days)
  • CASI 76.1K
  • OMH 221.4K
  • Earning Date
  • CASI 11-13-2025
  • OMH 09-25-2025
  • Dividend Yield
  • CASI N/A
  • OMH N/A
  • EPS Growth
  • CASI N/A
  • OMH N/A
  • EPS
  • CASI N/A
  • OMH N/A
  • Revenue
  • CASI $31,564,000.00
  • OMH $7,976,578.00
  • Revenue This Year
  • CASI N/A
  • OMH $28.40
  • Revenue Next Year
  • CASI N/A
  • OMH $23.07
  • P/E Ratio
  • CASI N/A
  • OMH N/A
  • Revenue Growth
  • CASI 36.64
  • OMH 117.53
  • 52 Week Low
  • CASI $1.09
  • OMH $0.59
  • 52 Week High
  • CASI $7.50
  • OMH $5.46
  • Technical
  • Relative Strength Index (RSI)
  • CASI 50.04
  • OMH 57.17
  • Support Level
  • CASI N/A
  • OMH $1.08
  • Resistance Level
  • CASI $2.49
  • OMH $1.60
  • Average True Range (ATR)
  • CASI 0.17
  • OMH 0.12
  • MACD
  • CASI -0.14
  • OMH 0.02
  • Stochastic Oscillator
  • CASI 80.40
  • OMH 56.36

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: